Application 761051

Type
BLA
Sponsor
KYOWA KIRIN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POTELIGEOMOGAMULIZUMAB-KPKCINJECTABLE;INJECTION20MG/5MLYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent
42747-761POTELIGEOmogamulizumab-kpkcKyowa Kirin, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85137SUPPL 2026-02-24
85100SUPPL 2026-02-23
80917SUPPL 2025-02-04
80911SUPPL 2025-02-04
70674SUPPL2022-03-31
70668SUPPL2022-03-31
68070SUPPL2021-07-13
68040SUPPL2021-07-12
55394ORIG2018-09-07
55133ORIG2018-08-08
55132ORIG2018-08-08